Essential Partners’s Cidara Therapeutics CDTX Stock Holding History

Essential Partners’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-50	Closed	-$11K	–	2869
2025 Q4	$11K	Buy	+50	New	+$8.08K	﹤0.01%	1140

Essential Partners's CDTX Position: Q1 2026 in Review

Essential Partners sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 50 shares — an estimated $11K sold.

Essential Partners first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $11K in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Essential Partners reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Essential Partners sold 50 Cidara Therapeutics shares in Q1 2026, an estimated $11K.
Essential Partners first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Essential Partners's Cidara Therapeutics position peaked at $11K in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Essential Partners's 13F filing for Q1 2026, filed 21 May 2026.